BioVie Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from BioVie Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 1,970% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 92% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 92% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Of every $100 of net worth, $97 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-209.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 92% of Healthcare companies in United States.
Cash Cushion Ratio
+78%Cash, after subtracting all debt, equals 78% of its market value (net cash).
Higher than 84% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 82% of Healthcare companies in United States.
Tangible Net Worth Ratio
97%Of every $100 of net worth, $97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 85% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
BioVie Inc. made a loss over the last year. BioVie Inc. owes $0.28 for every $1 it owns. BioVie Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
LossBioVie Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.08The share price is 1.08 times BioVie Inc.'s book value per share, lower than 77% of Healthcare companies in United States.
Market cap
$11 MThe total market value of all of BioVie Inc.'s shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$10 MWhat BioVie Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.18Net worth divided by the number of shares. The share price of $1.28 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-150.8%BioVie Inc. lost 150.8% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
Owes vs Owns
0.28×BioVie Inc. owes $0.28 for every $1 it owns (low), lower than 63% of Healthcare companies in United States.
Dividend yield
NoneBioVie Inc. does not currently pay a dividend.
Profit growth
LossBioVie Inc. made a loss in each of the last two years.
Interest cover
Not coveredBioVie Inc.'s operating profit did not cover its interest costs in the year to Jun 2026.
Cash vs debt
Net cashBioVie Inc. held $9 M more cash than debt (net cash) at Jun 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For BioVie Inc.: $11 M ÷ $10 M (30 Jun 2026) = 1.1.
What is BioVie Inc.'s return on equity?
BioVie Inc. lost 150.8% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
How much does BioVie Inc. owe compared with what it owns?
BioVie Inc. owes $0.28 for every $1 it owns (low), lower than 63% of Healthcare companies in United States.
Does BioVie Inc. pay a dividend?
No. BioVie Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.